Want to join the conversation?
$TMO said it completed the acquisition of Affymetrix at the end of March 2016 for $1.3Bil. Affymetrix is now part of the the Life Sciences Solutions segment. The company expects to generate $70MM of operating income synergies by year three following the close, $55MM from cost and $15MM from revenue.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.